Akèy › Fibroz sistik › Alabama
Etid klinik pou Fibroz sistik nan Alabama
16 etid pou Fibroz sistik ap chèche patisipan nan sit nan Alabama.
Vil nan Alabama
Tèks ofisyèl etid la (Anglè)
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- The Children's Hospital Alabama & University of Alabama at Birmingham, Birmingham
Ap rekrite
Laj 3 a 18 · Tout sèks · Mizajou Aug 3, 2026 · NCT06654752Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Jiska laj 10 · Tout sèks · Mizajou Jul 8, 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 4
Laj 6 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT055482834D-710 in Adult Patients With Cystic Fibrosis
- University of Alabama Child Health Research Unit, Birmingham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT05248230Ensuring Access to Optimal Therapy in CF: The ENACT Study
- The University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 4
Laj 3 ak plis · Tout sèks · Mizajou Jun 2, 2026 · NCT07148739Rare CFTR Mutation Cell Collection Protocol (RARE)
- University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyonMande peman pou patisipan yo
Laj 17 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT03161808Role of Body Fat Distribution in Metabolic and Pulmonary Decline in Cystic Fibrosis (ORBIT-CF)
- University of Alabama at Birmingham (UAB)/Children's of Alabama, Birmingham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 16 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT04002882Kidney Function in People With Cystic Fibrosis in the Era of HEMT
- University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT06595420Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
- University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT06837181Personalized Theratyping Trial
- University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 1 bonè
Laj 6 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT03587961OnTrackCF: Engagement, Feasibility, and Acceptability Study
- University of Alabama-Birmingham, Birmingham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 5, 2025 · NCT07031323Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- University of Alabama-Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06296394Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Nov 3, 2025 · NCT06683092IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
- University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2025 · NCT04294043A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Oct 1, 2025 · NCT06504589Study With Phage for CF Subjects With Pseudomonas Lung Infection
- University of Alabama at Birmingham, Birmingham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2025 · NCT06998043Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.